prevention | CARLAT PUBLISHING

Research Update

A Promising Combo: Olanzapine and Samidorphan

July 1, 2024

Earth Hasassri, MD. Dr. Hasassri has no financial relationships with companies related to this material.

When we must use antipsychotics (NbN D2 receptor blockers), we do whatever we can to avoid side effects from them. This research upside looks at the potential for the new olanzapine-semiglutide combination medication to reduce D2 blocker-related weight gain in children and teens.

Expert Q&A

Understanding Suicide: Prevention and Intervention Strategies

April 1, 2024

J. John Mann, MD

J. John Mann, MD.

Paul Janssen Professor of Translational Neuroscience in Psychiatry and Radiology; Director, Molecular Imaging and Neuropathology Division; Co-Director, Columbia Center for Prevention and Treatment of Depression, Columbia University/New York State Psychiatric Institute, New York, NY.

Dr. Mann receives royalties from the Research Foundation for Mental Hygiene for the commercial use of the Columbia-Suicide Severity Rating Scale and royalties from Columbia University for the Columbia Psychiatry Pathways app. Relevant financial relationships listed for the author have been mitigated.

We examine effective suicide prevention techniques, highlighting simple yet impactful methods such as post-hospitalization follow-ups via phone calls or postcards. Dr. Mann offers insight into these and other interventions that have been successful in lowering suicide rates.

Clinical Update

How to Identify and Treat Prodromal Symptoms of Bipolar Disorder and Schizophrenia

September 1, 2023

José S. Sanchez-Cruz, MD

José S. Sanchez-Cruz, MD. Chief Resident, Department of Psychiatry, NYU Langone Health, New York. Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC.

Dr. Sanchez-Cruz and Dr. Aiken have no financial relationships with companies related to this material.

Patients with genetic risks for schizophrenia and bipolar disorder often present with prodromal symptoms of the illness, but the most effective treatment may surprise some. It’s not a medication.

Readily Available and Easily Abused Over-the-Counter Medications

January 2, 2023

Joshua Feder, MD and Mara Goverman

Reviewing four commonly abused substances that are legally available for purchase: Dextromethorphan, antihistamines, pseudoephedrine, and Kratom.

Psychotherapy and Medication in Recurrent Depression

June 29, 2021

Giovanni Fava, MD

Giovanni Fava, MD

Clinical Professor of Psychiatry at the State University of New York at Buffalo. Editor-in-Chief of the journal Psychotherapy and Psychosomatics and author of over 500 scientific papers. His book, Discontinuing Antidepressant Medications, is due from Oxford University Press in 2021. Dr. Fava has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Antidepressants treat depression, but patients need something more to prevent future episodes. Giovanni Fava describes an evidence-based method that blends medication with psychotherapy in two phases: sequential treatment for prevention of depression.

Stigmatizing Smoking: An Effective Deterrent?

March 30, 2020

Benjamin Oldfield, MD

Benjamin Oldfield, MD Dr. Oldfield has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In a randomized controlled trial, researchers tested a statement that invokes shame in people who smoke cigarettes and measured how it impacts the time until they smoke the next cigarette.

Predicting and Preventing Fatal Opioid Overdoses

March 30, 2020

Kristen Gardner, PharmD

Kristen Gardner, PharmD Dr. Gardner has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In addition to when we prescribe opioids, there are other opportunities and interactions patients have with the health care system upon which we can intervene to mitigate overdose risk. This study describes some of those opportunities, many of which happen every day in addiction clinics.

Harm Reduction Strategies—A Primer

February 11, 2020

To minimize harm and optimize safety among people who use drugs, particularly injections drugs, learn the nuts and bolts of naloxone distribution, syringe exchange, pre-exposure prophylaxis (PrEP) for HIV prevention, and fentanyl testing.

EXPERT Q&A

The Clinician’s Role: Reducing Harm Among People Who Use Drugs

February 11, 2020

Kimberly Sue, MD, PhD

Kimberly Sue, MD, PhD
Medical Director of the Harm Reduction Coalition (www.harmreduction.org). Attending physician at Rikers Island Correctional Health Services, NY. Dr. Sue has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Addiction researcher and medical director of the Harm Reduction Coalition shares her approach to patients and provides state-specific resources for clinicians interested in connecting with harm reduction resources locally.

How to Talk to Patients About the Risk of Opioid Overdose

February 11, 2020

How do you engage patients in discussion surrounding overdose risk? Learn some evidence-based strategies that will build trust, be accessible and understandable to patients, and empower them to use as safely as possible.